FrancophonIA/ELRC3.0 huggingface dataset:
English: This compared with 5.1 to 5.6 mmHg in those using brinzolamide and 5.7 to 6.9 mmHg in those using timolol.
Croatian: U usporedbi s tim u bolesnika koji koriste brinzolamid zabilježeno je snižavanje za 5,1 na 5.6 mmHg i u bolesnika koji koriste timolol zabilježeno je snižavanje s 5,7 na 6,9 mmHg.
English: Azarga contains two active substances, brinzolamide and timolol.
Croatian: Azarga sadrži dvije djelatne tvari, brinzolamid i timolol.
English: The first was a six-month study comparing Azarga with brinzolamide and with timolol used on their own in 523 patients.
Croatian: Prvo ispitivanje je bilo šestomjesečno ispitivanje koje je usporedilo lijek Azarga s monoterapijama brinzolamidom i timololom u 523 bolesnika.
English: What is Azarga used for?
Croatian: Za što se Azarga koristi?
English: What benefit has Azarga shown during the studies?
Croatian: Koje su koristi lijeka Azarga dokazane u ispitivanjima?
English: How is Azarga used?
Croatian: Kako se Azarga koristi?
English: For the full list of all side effects reported with Azarga, see the package leaflet.
Croatian: Potpuni popis nuspojava zabilježenih pri primjeni lijeka Azarga, potražite u uputi o lijeku.
English: How does Azarga work?
Croatian: Kako djeluje Azarga?
English: How has Azarga been studied?
Croatian: Kako se Azarga ispitivao?
English: Xeloda must also not be used in the following groups:
Croatian: Xeloda se ne smije primjenjivati u sljedećim skupinama:
English: Xeloda is available as tablets (150 and 500 mg).
Croatian: Lijek Xeloda dostupan je u obliku tableta (150 i 500 mg).
English: The tablets are given twice daily for 14 days followed by a 7-day gap before the next course.
Croatian: Tablete se uzimaju dva puta dnevno tijekom 14 dana, nakon čega treba napraviti stanku od 7 dana prije sljedećeg ciklusa liječenja.
English: Xeloda tablets should be taken within 30 minutes after a meal.
Croatian: Tablete Xeloda uzimaju se 30 minuta nakon obroka.
English: Fluorouracil is very similar to pyrimidine.
Croatian: Fluorouracil je vrlo sličan pirimidinu.
English: For other types of cancer, treatment is stopped if the disease gets worse or the side effects are unacceptable.
Croatian: Kod drugih vrsta raka, liječenje se prekida ako se bolest pogorša ili ako nuspojave nisu prihvatljive.
English: • pregnant or breastfeeding women;
Croatian: • u trudnica ili dojilja;
English: The dose depends on the patient's height and weight and the type of cancer being treated.
Croatian: Doza ovisi o visini i težini bolesnika te o vrsti raka koji se liječi.
English: The safety profile of the medicine is considered acceptable.
Croatian: Sigurnosni profil lijeka Xeloda smatra se prihvatljivim.
English: What measures are being taken to ensure the safe and effective use of Xeloda?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Xeloda?
English: Pyrimidine is part of the genetic material of cells (DNA and RNA).
Croatian: Pirimidin je dio genetskog materijala stanica (DNK i RNK).
English: Xeloda is taken as tablets, while fluorouracil normally needs to be injected.
Croatian: Xeloda se uzima u obliku tableta, dok se fluorouracil obično treba ubrizgati.
English: • patients with complete absence of activity of the dihydropyrimidine dehydrogenase enzyme;
Croatian: • u bolesnika s potpunim izostankom aktivnosti enzima dihidropirimidin dehidrogenaze;
English: The European Medicines Agency therefore decided that Xeloda's benefits are greater than its risks and it can be authorised for use in the EU.
Croatian: Europska agencija za lijekove stoga je zaključila da koristi od lijeka Xeloda nadmašuju s njim povezane rizike te da lijek može biti odobren za primjenu u EU-u.
English: Other information about Xeloda
Croatian: Ostale informacije o lijeku Xeloda
English: • patients taking brivudine (an antiviral medicine for treating shingles or chickenpox) or who have taken it in the last 4 weeks.
Croatian: • u bolesnika koji uzimaju brivudin (protuvirusni lijek za liječenje herpes zostera ili vodenih kozica) ili koji su ga uzimali u posljednja 4 tjedna.
English: As a result, it prevents the growth of tumour cells and eventually kills them.
Croatian: Uslijed toga on blokira rast stanica tumora te naposljetku uzrokuje njihovu smrt.
English: The most common side effects with Xeloda are diarrhoea, nausea (feeling sick), vomiting, abdominal (belly) pain, stomatitis (sores in the mouth), palmar-plantar erythrodysaesthesia (hand-foot syndrome, a skin reaction with rash and pain on the hands and feet), tiredness, weakness, loss of appetite, problems due to formation of blood clots in the blood vessels, heart problems and kidney problems in patients who already have reduced kidney function.
Croatian: Najčešće nuspojave lijeka Xeloda jesu proljev, mučnina, povraćanje, bol u abdomenu (trbuhu), stomatitis (rane u ustima), sindrom palmarno-plantarne eritrodizestezije (sindrom dlanova i stopala, koji uključuje reakciju kože s osipom i bolovima u dlanovima i stopalima), umor, slabost, gubitak apetita, problemi zbog stvaranja krvnih ugrušaka u krvnim žilama, problemi sa srcem i problemi s bubrezima u bolesnika koji već imaju smanjenu funkciju bubrega.
English: • patients who have had severe and unexpected reactions to fluoropyrimidine therapy;
Croatian: • u bolesnika koji imaju ozbiljne i neočekivane reakcije na terapiju fluoropirimidinom;
English: Side effects reported with Xeloda are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek Xeloda pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
English: What is Xeloda and what is it used for?
Croatian: Što je Xeloda i za što se primjenjuje?
English: • patients with severe leucopenia, neutropenia, or thrombocytopenia (low levels of white cells or platelets in the blood);
Croatian: • u bolesnika s ozbiljnom leukopenijom, neutropenijom ili trombocitopenijom (niskim razinama bijelih stanica ili trombocita u krvi);
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Xeloda have been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Xeloda nalaze se u sažetku opisa svojstava i u uputi o lijeku.
English: In the body, fluorouracil takes the place of pyrimidine and interferes with the enzymes involved in making new DNA.
Croatian: U tijelu fluorouracil preuzima ulogu pirimidina i ometa enzime uključene u stvaranje novog DNK-a.
English: Further information on Xeloda can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/Xeloda.
Croatian: Lijek Xeloda dobio je odobrenje za stavljanje u promet koje je na snazi u EU-u od 2. veljače 2001. Više informacija o lijeku Xeloda nalazi se na internetskim stranicama Agencije: ema.europa.eu/medicines/human/EPAR/Xeloda.
English: • locally advanced or metastatic breast cancer (breast cancer that has begun to spread to other parts of the body).
Croatian: • lokalno uznapredovalog ili metastaziranog raka dojke (raka dojke koji se počeo širiti u druge dijelove tijela).
English: Treatment is continued for 6 months after colon surgery.
Croatian: Liječenje se provodi tijekom 6 mjeseci nakon kirurškog zahvata na debelom crijevu.
English: The disease responded in 19 to 25% of patients treated with Xeloda, compared with 12 to 15% with the comparator combination.
Croatian: Između 19 i 25 % bolesnika koji su bili liječeni lijekom Xeloda odgovorilo je na liječenje, u usporedi s 12 do 15 % bolesnika liječenih usporednom kombinacijom.
English: As for all medicines, data on the use of Xeloda are continuously monitored.
Croatian: Kao i za sve lijekove, podatci o primjeni lijeka Xeloda kontinuirano se prate.
English: • advanced gastric (stomach) cancer.
Croatian: • uznapredovalog gastričnog raka (raka želuca).
English: Doses need to be adjusted for patients with liver or kidney disease and for patients who develop certain side effects.
Croatian: Doze se moraju prilagoditi bolesnicima s oboljenjima jetre ili bubrega i u bolesnika kod kojih se pojave određene nuspojave.
English: Xeloda has been shown to be effective in treating colon, colorectal, gastric and breast cancer.
Croatian: Lijek Xeloda pokazao se učinkovitim u liječenju raka debelog crijeva, kolorektalnog raka, gastričnog raka i raka dojke.
English: It took 5.6 months for the disease to get worse in patients taking Xeloda and cisplatin, and 5.0 months in patients receiving fluorouracil and cisplatin.
Croatian: Bolest se pogoršala za 5,6 mjeseci u bolesnika koji su primali lijek Xeloda i cisplatin, te za 5,0 mjeseci u bolesnika koji su primali fluorouracil i cisplatin.
English: What are the risks associated with Xeloda?
Croatian: Koji su rizici povezani s lijekom Xeloda?
English: Why is Xeloda authorised in the EU?
Croatian: Zašto je lijek Xeloda odobren u EU-u?
English: Xeloda should only be prescribed by a doctor who is experienced in the use of cancer medicines.
Croatian: Lijek Xeloda treba propisati samo liječnik s iskustvom u primjeni lijekova protiv raka.
English: Xeloda is a cancer medicine that is used to treat:
Croatian: Xeloda je lijek za liječenje raka koji se primjenjuje za liječenje:
English: For more information about using Xeloda, see the package leaflet or contact your doctor or pharmacist.
Croatian: Više informacija o primjeni lijeka Xeloda pročitajte u uputi o lijeku odnosno obratite se liječniku ili ljekarniku.
English: An overview of Xeloda and why it is authorised in the EU
Croatian: Pregled informacija o lijeku Xeloda i zašto je odobren u EU-u
English: About two-thirds of the patients taking Xeloda or the combination remained disease-free throughout the 3.8 years of the study.
Croatian: U oko dvije trećine bolesnika koji su uzimali lijek Xeloda ili kombinaciju bolest se nije vratila u razdoblju od 3,8 godina koliko je trajalo ispitivanje.
English: • metastatic colorectal cancer (cancer of the large bowel that has spread to other parts of the body).
Croatian: • metastaziranog kolorektalnog raka (raka debelog crijeva koji se proširio na ostale dijelove tijela).
English: Also, the results of a published study involving 1,002 patients showed that patients taking combinations of medicines that included Xeloda survived for a similar period as those taking combinations that included fluorouracil.
Croatian: Isto tako, rezultati objavljenog ispitivanja koje je obuhvatilo 1 002 bolesnika pokazali su da su bolesnici koji su uzimali kombinacije lijekova koje su uključivale lijek Xeloda podjednako dugo preživjeli kao oni koji su uzimali kombinacije koje su uključivale fluorouracil.
English: Xeloda must not be used in people who may be hypersensitive (allergic) to capecitabine, to any of the other ingredients, or to fluorouracil.
Croatian: Lijek Xeloda ne smiju uzimati osobe preosjetljive (alergične) na kapecitabin, bilo koji drugi sastojak lijeka ili fluorouracil.
English: Two smaller studies (238 patients) showed that Xeloda was effective after treatment with taxanes and anthracyclines did not work.
Croatian: U dvama manjim ispitivanjima (na 238 bolesnica) pokazalo se da je lijek Xeloda bio učinkovit nakon neuspješnog liječenja taksanima i antraciklinima.
English: Results showed that when either Xeloda or fluorouracil and folinic acid were used with oxaliplatin, it took an average of 8 months for the disease to get worse in patients who had not been treated before, and 5 months in patients whose previous treatment had not worked.
Croatian: Rezultati su pokazali da kada su se lijek Xeloda ili fluorouracil i folna kiselina primjenjivali s oksaliplatinom, bolest se u bolesnika koji prethodno nisu bili liječeni pogoršala u prosjeku za 8 mjeseci, u odnosu na 5 mjeseci u bolesnika kod kojih prethodno liječenje nije bilo uspješno.
English: Xeloda is used with other cancer medicines, including a platinum-containing cancer medicine such as cisplatin;
Croatian: Xeloda se primjenjuje u kombinaciji s drugim lijekovima za liječenje raka, uključujući lijekove protiv raka koji sadrže platinu, kao što je cisplatin;
English: Capecitabine is a ‘prodrug' that is converted to the medicine fluorouracil in the body, but more is converted in tumour cells than in normal tissues.
Croatian: Kapecitabin je prolijek koji se u tijelu pretvara u lijek fluorouracil, i to u većoj mjeri u stanicama tumora nego u zdravom tkivu.
English: Patients taking Xeloda with docetaxel had a longer time before the disease got worse compared with patients taking docetaxel on its own (186 days compared with 128 days).
Croatian: Za bolesnice koje su uzimale lijek Xeloda kombiniran s docetakselom produljeno je razdoblje do pogoršanja bolesti u odnosu na bolesnice koje su primale monoterapiju docetaksela (186 dana u usporedbi sa 128 dana).
English: Another study involving 1,886 patients who had had surgery showed that Xeloda together with oxaliplatin (another cancer medicine) was more effective than the combination of fluorouracil and folinic acid: patients taking Xeloda and oxaliplatin had 20% lower risk of getting cancer again or death compared with patients taking fluorouracil and folinic acid.
Croatian: U drugom ispitivanju koje je obuhvatilo 1 886 bolesnika podvrgnutih kirurškom zahvatu pokazalo se da je lijek Xeloda u kombinaciji s oksaliplatinom (drugim lijekom protiv raka) učinkovitiji od kombinacije fluorouracila i folne kiseline: bolesnici koji su uzimali lijek Xeloda i oksaliplatin imali su 20 % manji rizik od ponovnog oboljenja od raka ili smrti u odnosu na bolesnike koji su uzimali fluorouracil i folnu kiselinu.
English: Xeloda has also been compared with the combination of fluorouracil and folinic acid, both used in combination with oxaliplatin, in 2 studies: the first involved 2,035 patients who had not been treated before, and the second involved 627 patients in whom previous treatment with irinotecan and a fluoropyrimidine (a group of cancer medicines that includes fluorouracil) had not worked.
Croatian: U dvama ispitivanjima lijek Xeloda uspoređivan je i s kombinacijom fluorouracila i folne kiseline, koji su se oboje uzimali s oksaliplatinom: prvo ispitivanje obuhvatilo je 2 035 bolesnika koji prethodno nisu bili liječeni, a u drugo ispitivanje bilo je uključeno 627 bolesnika kod kojih prethodno liječenje irinotekanom i fluoropirimidinom (skupina lijekova za liječenje raka koja uključuje fluorouracil) nije bilo uspješno.
English: • patients with severe liver or kidney disease;
Croatian: • u bolesnika s ozbiljnim bolestima jetre ili bubrega;
English: Xeloda is used with docetaxel (another cancer medicine) after treatment with anthracyclines (another type of cancer medicine) has failed.
Croatian: Xeloda se primjenjuje u kombinaciji s docetakselom (drugim lijekom protiv raka) nakon neuspješne terapije antraciklinima (drugom vrstom lijeka protiv raka).
English: How does Xeloda work?
Croatian: Kako djeluje Xeloda?
English: Gastric cancer
Croatian: Gastrični rak
English: What benefits of Xeloda have been shown in studies?
Croatian: Koje su koristi od lijeka Xeloda utvrđene u ispitivanjima?
English: Xeloda is used on its own or with other cancer medicines in patients who have had surgery for stage III or Dukes' stage C colon cancer;
Croatian: Xeloda se primjenjuje kao monoterapija ili u kombinaciji s drugim lijekovima za liječenje raka u bolesnika koji su operirali rak debelog crijeva „stadija III” ili „stadija C” prema Dukesovoj klasifikaciji;
English: The active substance in Xeloda, capecitabine, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells) that belongs to the group ‘anti-metabolites'.
Croatian: Djelatna tvar lijeka Xeloda, kapecitabin, citotoksičan je lijek (lijek koji uzrokuje smrt stanica koje se dijele, kao što su stanice raka) i ubraja se u skupinu „antimetabolita”.
English: It can also be used on its own when treatment with both anthracyclines and taxanes (another type of cancer medicine) has failed or when further treatment with anthracyclines is not suitable for the patient.
Croatian: Xeloda se može primjenjivati i kao monoterapija ako liječenja antraciklinima i taksanima (drugom vrstom lijeka protiv raka) nisu bila uspješna ili ako ponovljeno liječenje antraciklinima nije primjereno za bolesnika.
English: In locally advanced or metastatic breast cancer, Xeloda with docetaxel was more effective than docetaxel on its own in a study involving 511 women.
Croatian: U slučaju lokalno uznapredovalog ili metastaziranog raka dojke, lijek Xeloda kombiniran s docetakselom bio je učinkovitiji od monoterapije docetaksela u ispitivanju koje je obuhvatilo 511 žena.
English: In advanced gastric cancer, Xeloda with cisplatin was as effective as a combination of fluorouracil and cisplatin in slowing down the disease in a study involving 316 patients.
Croatian: U slučaju uznapredovalog gastričnog raka, lijek Xeloda s cisplatinom bio je jednako učinkovit kao i kombinacija fluorouracila i cisplatina u usporavanju bolesti u jednom ispitivanju kojim je bilo obuhvaćeno 316 bolesnika.
English: How is Xeloda used?
Croatian: Kako se Xeloda primjenjuje?
English: Xeloda is used on its own or with other cancer medicines;
Croatian: Xeloda se primjenjuje kao monoterapija ili u kombinaciji s drugim lijekovima protiv raka;
English: Colorectal cancer
Croatian: Kolorektalni rak
English: • colon (large bowel) cancer.
Croatian: • raka kolona (debelog crijeva).
English: In metastatic colorectal cancer, Xeloda taken on its own was as effective as the combination of fluorouracil and folinic acid in 2 studies involving 1,207 patients.
Croatian: U slučaju metastaziranog kolorektalnog raka, lijek Xeloda koji se uzimao kao monoterapija bio je jednako učinkovit kao fluorouracil i folna kiselina u dvama ispitivanjima koja su uključivala 1 207 bolesnika.
English: For the full list of side effects reported with Xeloda, see the package leaflet.
Croatian: Potpuni popis nuspojava zabilježenih pri primjeni lijeka Xeloda potražite u uputi o lijeku.
English: In colon cancer, Xeloda on its own has been shown to be as effective as the combination of fluorouracil and folinic acid (a medicine that enhances the effects of fluorouracil) in a main study involving 1,987 patients who had had surgery for their cancer.
Croatian: Kod raka debelog crijeva, lijek Xeloda koji se uzimao kao monoterapija bio je jednako učinkovit kao i kombinacija fluorouracila i folne kiseline (lijeka koji pojačava učinak fluorouracila) u glavnom ispitivanju koje je obuhvatilo 1 987 bolesnika koji su operirali rak.
English: Xeloda contains the active substance capecitabine.
Croatian: Xeloda sadržava djelatnu tvar kapecitabin.
English: 3.3 mg Powder for suspension for implantation
Croatian: 3,3 mg Prašak za suspenziju za implantat
English: 1 g
Croatian: staklenoj bočica 1g
English: Invented name Strength Pharmaceutical Form Route of Administration
Croatian: Farmaceutski oblik
English: Intraosseous use Vial (glass)
Croatian: Za intraosealnu primjenu.
English: This summary was last updated in 05-2017.
Croatian: Sažetak je posljednji put ažuriran u 05. 2017.
English: Pregabalin Mylan Pharma is available as capsules (25, 50, 75, 100, 150, 200, 225 and 300 mg) and can only be obtained with a prescription.
Croatian: Lijek Pregabalin Mylan Pharma dostupan je u kapsulama (25, 50, 75, 100, 150, 200, 225 i 300 mg), a izdaje se samo na liječnički recept.
English: This reduces the activity of some of the nerve cells in the brain and spinal cord, reducing the release of other neurotransmitters that are involved in pain, epilepsy and anxiety.
Croatian: Time se smanjuje aktivnost pojedinih živčanih stanica u mozgu i kralježničkoj moždini, što smanjuje otpuštanje drugih neurotransmitera koji uzrokuju bol, epilepsiju i anksioznost.
English: After one week, the dose can be increased to 300 mg per day.
Croatian: Nakon tjedan dana, doza se može povećati na 300 mg na dan.
English: • epilepsy, where it is used as an ‘add-on' to other epilepsy treatment in patients who have partial seizures (epileptic fits starting in one specific part of the brain);
Croatian: • epilepsijom, kada se koristi kao dodatna terapija drugoj terapiji za liječenje epilepsije u bolesnika koji imaju parcijalne napadaje (epileptične napadaje koji izbijaju u specifičnom dijelu mozga),
English: The full EPAR for Pregabalin Mylan Pharma can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR za lijek Pregabalin Mylan Pharma nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: This means that Pregabalin Mylan Pharma contains the same active substance and works in the same way as a ‘reference medicine' already authorised in the European Union (EU) called Lyrica.
Croatian: To znači da Pregabalin Mylan Pharma sadrži istu djelatnu tvar i djeluje na isti način kao i „referentni lijek” koji je već odobren u Europskoj uniji (EU) pod nazivom Lyrica.
English: To stop treatment with Pregabalin Mylan Pharma the dose should be reduced gradually, over at least a week.
Croatian: Prekid terapije lijekom Pregabalin Mylan Pharma treba provoditi postupnim smanjivanjem doze tijekom najmanje tjedan dana.
English: For more information on generic medicines, see the questionand-answer document here.
Croatian: Više informacija o generičkim lijekovima potražite u dokumentu s pitanjima i odgovorima ovdje
English: The active substance in Pregabalin Mylan Pharma, pregabalin, is similar in structure to the body's own ‘neurotransmitter' gamma‑amino butyric acid (GABA), but has very different biological effects.
Croatian: Djelatna tvar lijeka Pregabalin Mylan Pharma, pregabalin, sličan je po strukturi neurotransmiteru gama-aminobutiričnoj kiselini (GABA) u organizmu, no ima vrlo različito biološko djelovanje.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Pregabalin Mylan Pharma has been shown to have comparable quality and to be bioequivalent to Lyrica.
Croatian: Odbor za lijekove za humanu uporabu (CHMP) pri Agenciji zaključio je kako je, u skladu sa zahtjevima EU-a, potvrđeno da Pregabalin Mylan Pharma posjeduje usporedivu kvalitetu te je bioekvivalentan lijeku Lyrica.
English: Studies on the benefits and risks of the active substance in the approved uses have already been carried out with the reference medicine, Lyrica, and do not need to be repeated for Pregabalin Mylan Pharma.
Croatian: Ispitivanja omjera koristi i rizika djelatne tvari u odobrenim primjenama već su provedena s referentnim lijekom Lyrica i ne treba ih ponavljati za lijek Pregabalin Mylan Pharma.
English: Because Pregabalin Mylan Pharma is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Croatian: Budući da je Pregabalin Mylan Pharma generički lijek te je bioekvivalentan referentnom lijeku, smatra se da su njegove koristi i rizici isti kao i oni referentnog lijeka.
English: As for every medicine, the company provided studies on the quality of Pregabalin Mylan Pharma.
Croatian: Kao i za svaki lijek, tvrtka je dostavila ispitivanja o kvaliteti lijeka Pregabalin Mylan Pharma.
English: This is a summary of the European public assessment report (EPAR) for Pregabalin Mylan Pharma.
Croatian: Ovo je sažetak europskoga javnog izvješća o procjeni (EPAR) lijeka Pregabalin Mylan Pharma.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Pregabalin Mylan Pharma have been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Pregabalin Mylan Pharma nalaze se u sažetku opisa svojstava i u uputi o lijeku.
English: Pregabalin Mylan Pharma is a medicine used to treat adults with the following conditions:
Croatian: Pregabalin Mylan Pharma je lijek koji se koristi za liječenje odraslih osoba s: